Miami, FL And Jersey City, NJ, October 15, 2019 — Noven Pharmaceuticals, Inc., a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., today announced the U.S. Food and Drug Administration (FDA) has approved Secuado (asenapine)…Original Article
FDA Approves Secuado (asenapine) Transdermal System for the Treatment of Adults with Schizophrenia
